Citation:Priestman TJ, Dunn J, Brada M, Rampling R, Baker PG 1996

From Cancer Guidelines Wiki

Citation


Priestman TJ, Dunn J, Brada M, Rampling R, Baker PG. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol (R Coll Radiol) 1996;8(5):308-15 Available from: http://www.ncbi.nlm.nih.gov/pubmed/8934050.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Priestman TJ, Dunn J, Brada M, Rampling R, Baker PG 1996What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?Associate Professor Shalini Vinod MBBS MD FRANZCRcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Priestman_TJ,_Dunn_J,_Brada_M,_Rampling_R,_Baker_PG_1996&oldid=21453"